BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21035463)

  • 1. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
    Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
    J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidate.
    Foucault M; Mayol K; Receveur-Bréchot V; Bussat MC; Klinguer-Hamour C; Verrier B; Beck A; Haser R; Gouet P; Guillon C
    Proteins; 2010 May; 78(6):1441-56. PubMed ID: 20034112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
    Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
    J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of antibody specificity. Detailed comparison of five Fab'-steroid complexes.
    Arevalo JH; Hassig CA; Stura EA; Sims MJ; Taussig MJ; Wilson IA
    J Mol Biol; 1994 Sep; 241(5):663-90. PubMed ID: 8071992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A; Chow KC; Pan OC; Scott JK
    J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
    Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP
    Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
    Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
    J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.
    Cardoso RM; Brunel FM; Ferguson S; Zwick M; Burton DR; Dawson PE; Wilson IA
    J Mol Biol; 2007 Feb; 365(5):1533-44. PubMed ID: 17125793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide.
    Anderson DC; Nichols E; Manger R; Woodle D; Barry M; Fritzberg AR
    Biochem Biophys Res Commun; 1993 Jul; 194(2):876-84. PubMed ID: 8343170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
    Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S
    Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex.
    Sogabe S; Stuart F; Henke C; Bridges A; Williams G; Birch A; Winkler FK; Robinson JA
    J Mol Biol; 1997 Nov; 273(4):882-97. PubMed ID: 9367779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.